Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) kicked off on Monday, down -0.45% from the previous trading day, before settling in for the closing price of $4.43.
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) flaunted slowness of -1.75% at $4.50, before settling in for the price of $4.58 at the close. Taking a more
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) on Monday, plunged -2.10% from the previous trading day, before settling in for the closing price of $4.77. Within the
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) open the trading on Thursday, with great promise as it jumped 4.72% to $5.10, before settling in for the price
On Monday, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was 0.22% up from the session before settling in for the closing price of $4.60. A 52-week range
Witnessing the stock’s movement on the chart, on Thursday, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) had a quiet start as it plunged -2.75% to $4.60, before
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) kicked off on Monday, down -0.59% from the previous trading day, before settling in for the closing price of $5.08.
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) started the day on Wednesday, with a price increase of 2.79% at $5.15, before settling in for the price of
May 22, 2023, BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) trading session started at the price of $8.43, that was 1.54% jump from the session before. During
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
